Third Point’s Horizon Therapeutics HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-500,000
Closed -$51.4M – 54
2023
Q2
$51.4M Buy
+500,000
New +$52.8M 0.75% 27

Other funds holding HZNP

Third Point's HZNP Position: Q3 2023 in Review

Third Point sold out of Horizon Therapeutics (HZNP) in Q3 2023, closing a stake of 500,000 shares — an estimated $51.4M sold.

Third Point first reported a position in HZNP in Q2 2023 and held it in 1 quarter. The position peaked at $51.4M in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Third Point reported no remaining Horizon Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Third Point sold 500,000 Horizon Therapeutics shares in Q3 2023, an estimated $51.4M.
  • Third Point first reported a position in Horizon Therapeutics in Q2 2023 and held it in 1 quarter.
  • Third Point's Horizon Therapeutics position peaked at $51.4M in Q2 2023.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q3 2023.

Based on Third Point's 13F filing for Q3 2023, filed 14 Nov 2023.